BioWave Corporation
The Next Generation of Long-Lasting Pain Relief

For many suffering from chronic pain, relief is often frustratingly short-lived. Conventional treatments—over-the-counter medications, prescription drugs, physical therapy and traditional transcutaneous electrical nerve stimulation (TENS) units—may offer temporary respite, but they fail to provide deep, lasting relief. The problem is how these methods address pain. Rather than targeting the source, they merely mask symptoms or provide surface-level stimulation.

BioWave is changing that. Its patented smarter pain-blocking technology stops pain signals before they reach the brain. And unlike traditional electrical stimulation, which struggles to penetrate beyond the skin, BioWave’s high-frequency neurostimulation bypasses the skin’s natural impedance, reaching deep into pain fibers and disrupting nerve activity at the source.

Designed for Everyone, Trusted by the Best

Designed for simplicity and effectiveness, the non-invasive device requires no complex programming. A simple power button and plus/minus controls allow users to adjust intensity from 0 to 100 percent, ensuring a customized experience based on individual pain sensitivity. The treatment is comfortable and feels like a deep, smooth pressure sensation, ensuring compliance and making it effective for long-term use.

The results speak for themselves. Clinical data shows that a single 30-minute session provides pain relief lasting up to eight hours and with percutaneous electrodes, for as long as several days.

“As a powerful, non-opioid and non-surgical alternative, our solution helps patients manage chronic, acute and post-operative pain, allowing them to return to their daily activities with greater ease,” says Bradford Siff, founder and president.

Backed by clinical data, FDA clearance, CE certification and a growing community of success stories—with over 2,300 five-star reviews—BioWave is more than just a pain relief device; it’s a movement transforming the way people manage pain.

Clinical data reinforces the impact. In a study of more than 8,600 patients, the average pre-treatment pain score of 7.9 dropped to 3.9 post-treatment, a 50 percent reduction in pain. There was also a significant improvement in mood and sleep. This validation shows how BioWave empowers patients to take control of their pain without surgery, medication or compromise.

Tailored Solutions for Every Need

BioWave offers advanced pain relief technology through three specialized devices—BioWavePRO, BioWaveHOME and BioWaveGO—each designed for specific treatment settings and powered by rechargeable batteries for convenience. BioWavePRO is a professional grade device intended for use in hospitals, clinics and athletic training rooms, while BioWaveHOME is a prescription strength treatment for home use that is prescribed to patients who respond to treatment with BioWavePRO in the clinic. BioWaveGO is a smaller over the counter version of BioWaveHOME that fits in one’s pocket, works with a smartphone app and allows the user to control and track the treatment while they’re on the go.

The strongest, most advanced pain treatment is BioWavePENS, an in-office medical procedure conducted under the supervision of a physician, using a BioWavePRO device combined with a unique patented pair of sterile, single-use microneedle percutaneous electrode arrays, that deliver up to 72 hours of continuous relief from a single 30-minute session. Each percutaneous electrode is comprised of over 1000 microneedles each 0.74mm in length that are inserted through the epidermis and provide a direct conductive pathway through skin, bypassing the impedance and other electrical properties of skin, which allow for deeper penetration of the active electrical field which provides enhanced efficacy and prolonged pain relief. Percutaneous electrodes are comfortable for patients and feel like Velcro to the touch.

Initially developed for professional sports, BioWave was first introduced through a clinical study with the New York Giants, focusing on treating acute and chronic sports injuries. Since then, BioWave has been purchased by the majority of professional sports teams in the NFL, MLB, NBA, NHL and MLS, helping athletes manage pain and accelerate recovery and return to play following injury and surgery.

BioWave is making a real difference in the lives of veterans. What started in just two VA hospitals in 2017 has now expanded to over 250 facilities nationwide, where the company is offering both non-invasive and percutaneous alternatives to traditional pain management. By addressing pain without relying on opioids or invasive procedures, it is helping veterans move more freely and reclaim a better quality of life.

For those seeking relief at home, BioWaveHOME empowers patients to reduce hospital visits while maintaining prescription-strength relief. On the move, BioWaveGO becomes a portable ally that allows users to manage discomfort.

One of the newest additions to BioWave’s medical device portfolio are BioWraps, which combine the benefits of electrical stimulation with compression in a wearable electrode garment. BioWraps are a unique patented design that utilizes very large fixed silver fabric electrodes, that allow for the treatment of up to 6X the volume of tissue as compared to conventional electrodes, while maintaining comfort and flexibility. Currently available for the back, knee, foot and ankle, hand and wrist, thigh and calf, BioWraps are also being developed for additional applications.

This breakthrough has been particularly effective in relieving phantom limb pain, offering comfort where few solutions exist. BioWave is beneficial for menstrual cramps, pelvic floor pain (including interstitial cystitis) and migraines. For migraine sufferers, placing electrodes on the back of the neck or head (bi-occiput placement) stimulates the occipital nerve, creating a gentle, soothing sensation that radiates to the crown of the head, helping to ease pain and tension.

The Vision Behind BioWave

For Siff, pain relief isn’t just a business—it’s a heartfelt mission driven by personal experience.

After suffering a severe skiing accident that led to reconstructive knee surgery, Siff had a devastating reaction to opioids, leaving him hospitalized for days. Determined to find a better solution, he turned to an early prototype of BioWave. The results were life-changing.

This experience fueled Brad’s mission: to create a smarter, opioid-free way to relieve pain. He assembled a team of top clinical and product development experts and BioWave was born, a non-surgical, non-opioid, high-frequency neurostimulation technology that truly works.

More Than Just Relief—A New Way to Live

BioWave is changing lives—not just by reducing pain, but by giving people back their freedom, mobility and quality of life.